Stimwave Technologies Provides Reimbursement Update

POMPANO BEACH, Fla.--(BUSINESS WIRE)--Today Stimwave Technologies provided an update on recent reimbursement-related progress.

U.S. (CPT®) Code Update

In February of 2022, the American Medical Association’s CPT® Editorial Panel updated a set of CPT® Codes related to the Company’s portfolio of products, including both its Freedom SCS and Freedom PNS platforms. This update provides clarification for various existing codes, through description modifications, while also setting the path for additional codes in the future.

Below is a summary of the changes, within Tab 11, which will go into effect January 1, 2024.

https://www.ama-assn.org/system/files/cpt-summary-panel-actions-feb-2022.pdf

• Accepted revision of codes 63685, 63688, 64590, 64595
• Addition of Category I codes 64XX2, 64XX3, 64XX4
• Addition of Category III codes 0X43T, 0X44T, X004T, 0X46T, X005T, 0X48T
• Accepted revision of Category III codes 0587T, 0588T, 0589T, 0590T
• Revision and addition of the Spine and Spinal Cord/Neurostimulators (Spinal) and the Extracranial Nerve, Peripheral Nerves, and Autonomic Nervous System Neurostimulators (Peripheral Nerve) guidelines

“This milestone is the culmination of the collaboration and hard work from our team, industry partners, leading physicians and supporting medical society,” said Aure Bruneau, Chief Executive Officer. “The update, supported by the body of clinical evidence, provides additional appropriate choices for physicians and the patients they treat, while also continuing to highlight our platforms’ ability to transform the lives of those suffering from chronic pain.”

About Stimwave Technologies

Stimwave Technologies is a medical device company that develops, manufactures and markets, neuromodulation products. Its Peripheral Nerve Stimulation (PNS) and Spinal Cord Stimulation (SCS) products are implanted technology that block pain signals to the brain and provide a drug-free alternative for treating patients suffering from chronic pain. Stimwave Technologies’ Freedom Systems, the SCS and PNS products, provide a unique and innovative technology with an HF-EMC wireless energy transfer from an external transmitter and antenna to the implanted electrode array and separate receiver. Stimwave Technologies’ FDA-cleared product portfolio can treat nerves from the neck down that are causing pain. Stimwave Technologies’ principal place of business is in Pompano Beach, Florida and it operates worldwide through its operating subsidiaries. For more information, please visit https://stimwavefreedom.com/.